A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | Clinical Trial Compass
SuspendedNot Applicable
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Stopped: Administrative
United States1,000 participantsStarted 2019-07-11
Plain-language summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Who can participate
Age range12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
* 2\. Male or female patients of any age (interest is given to children to compare with mothers).
Exclusion Criteria:
* 1\. Refusal to sign informed consent form
* 2\. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
* 3\. Postoperative stoma, ostomy, or ileoanal pouch
* 4\. Participation in any experimental drug protocol within the past 12 weeks
* 5\. Treatment with total parenteral nutrition
* 6\. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
* 7\. Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study
What they're measuring
1
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing